Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome.

PubWeight™: 2.56‹?› | Rank: Top 1%

🔗 View Article (PMID 4267356)

Published in Mayo Clin Proc on May 01, 1973

Authors

F C McDuffie, W M Sams, J E Maldonado, P H Andreini, D L Conn, E A Samayoa

Articles citing this

Metabolic studies of the third component of complement and the glycine-rich beta glycoprotein in patients with hypocomplementemia. J Clin Invest (1974) 2.81

Hypocomplementemic urticarial vasculitis syndrome: an interdisciplinary challenge. Dtsch Arztebl Int (2009) 1.84

Circulating immune complexes in cutaneous vasculitis. Detection with C1q and monoclonal rheumatoid factor. J Clin Invest (1979) 1.01

Lymphocytes in rheumatoid and nonrheumatoid synovial fluids. Nonspecificity of high T-cell and low B-cell percentages. Ann Rheum Dis (1975) 1.00

Hypocomplementemic urticarial vasculitis syndrome: a case report and literature review. J Clin Aesthet Dermatol (2012) 0.90

Elevated serum levels of visfatin in patients with henoch-schönlein purpura. Ann Dermatol (2014) 0.85

Juvenile systemic lupus erythematosus and dermatomyositis associated with urticarial vasculitis syndrome: a unique presentation. Rheumatol Int (2010) 0.83

Urticarial vasculitis in northern Spain: clinical study of 21 cases. Medicine (Baltimore) (2014) 0.82

Inflammatory myositis complicating hypocomplementemic urticarial vasculitis despite on-going immunosuppression. Clin Rheumatol (2006) 0.81

Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement. Clin Exp Immunol (1987) 0.80

Membranoproliferative glomerulonephritis presenting as arthropathy and cardiac valvulopathy in hypocomplementemic urticarial vasculitis: a case report. J Med Case Rep (2014) 0.80

A complete selective C1q deficiency in a patient with discoid lupus erythematosus (DLE). Clin Exp Immunol (1982) 0.79

Immunofluorescent investigations in cutaneous vasculitis. I. Histotopical demonstration of complement/complement factors. Arch Dermatol Res (1975) 0.78

Hypocomplementemic urticarial vasculitis (HUVS) with precocious emphysema responsive to azathioprine. J Clin Immunol (2013) 0.76

Urticarial vasculitis--response to gold therapy. J R Soc Med (1991) 0.76

Hypocomplementemic Urticarial Vasculitis Syndrome in an 8-year-old Boy: A Case Report and Review of Literature. Oman Med J (2013) 0.76

Pseudotumour cerebri in association with polyarthritis, urticaria and cryoglobulinemia. Can Med Assoc J (1985) 0.75

Phaeochromocytoma in a patient with primary hypogonadism and a bicuspid aortic valve. Proc R Soc Med (1974) 0.75

Chronic urticaria. West J Med (1990) 0.75

Urticarial Vasculitis-Associated Intestinal Ischemia. Case Rep Gastrointest Med (2016) 0.75

Cutaneous vasculitis and hypocomplementaemia. Proc R Soc Med (1974) 0.75

Editorial: Complement activation and disease. Br Med J (1976) 0.75

Recurrent angioedema and urticaria. West J Med (1993) 0.75

Complement activation profiles in disease. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.75

MacDuffie syndrome and primary sclerosing cholangitis: an exceptional association. Dig Dis Sci (2006) 0.75

Hypocomplementemic Urticarial Vasculitis Syndrome with Membranous Nephropathy: Case Report. J Korean Med Sci (2017) 0.75

Urticaria vasculitis in a child: a case report and literature review. Clin Case Rep (2017) 0.75

Articles by these authors

Multiple and ancient origins of the domestic dog. Science (1997) 27.18

The influence of HLA-DRB1 genes on disease severity in rheumatoid arthritis. Ann Intern Med (1992) 3.36

Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases. N Engl J Med (1976) 3.22

Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. J Rheumatol (1989) 2.67

Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc (1980) 2.04

Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J Clin Invest (1976) 1.96

Identification of a major basic protein in guinea pig eosinophil granules. J Exp Med (1973) 1.87

Immune complexes in sera and synovial fluids of patients with rheumatoid arthritis. Radioimmunoassay with monocylonal rheumatoid factor. J Clin Invest (1975) 1.86

Nonsystemic vasculitic neuropathy. Brain (1987) 1.84

Complement immunofluorescent staining in bullous pemphigoid. J Lab Clin Med (1969) 1.83

Rheumatic manifestations in myelodysplastic syndromes. J Rheumatol (1991) 1.82

Fanconi syndrome in adults. A manifestation of a latent form of myeloma. Am J Med (1975) 1.70

Plasma cell leukemia. Report on 17 cases. Arch Intern Med (1974) 1.66

Role of the bursa of Fabricius in IgG and IgM production in the chicken: evidence for the role of a non-bursal site in the development of humoral immunity. J Immunol (1971) 1.65

Phylogenetic relationships, evolution, and genetic diversity of the domestic dog. J Hered (1999) 1.62

Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum (1972) 1.56

Chronic idiopathic intestinal pseudo-obstruction. Am J Med (1970) 1.55

Interaction of coagulation factor V and factor Va with platelets. J Biol Chem (1979) 1.53

Leukocytoclastic vasculitis. Arch Dermatol (1976) 1.52

Necrotizing vasculitis. J Am Acad Dermatol (1980) 1.52

Hypocomplementemia in rheumatoid arthritis. Am J Med (1973) 1.50

Immunologic mechanisms in systemic vasculitis. Mayo Clin Proc (1976) 1.50

Systemic giant-cell arteritis with polymyalgia rheumatica, reversible abnormalities of liver function. JAMA (1973) 1.48

Rifampin therapy in rheumatoid arthritis. J Rheumatol (1990) 1.47

Erythema ab igne: a histopathological study. J Invest Dermatol (1966) 1.46

Immunofluorescence of cutaneous vasculitis associated with systemic disease. Arch Dermatol (1971) 1.38

Cutaneous vessel immune deposits in rheumatoid arthritis. Arthritis Rheum (1976) 1.38

Cimetidine as an immunomodulator: chronic mucocutaneous candidiasis as a model. Ann Intern Med (1980) 1.37

Necrotizing angiopathic neuropathy. Three-dimensional morphology of fiber degeneration related to sites of occluded vessels. Mayo Clin Proc (1972) 1.37

Rheumatoid vasculitis: survival and associated risk factors. Medicine (Baltimore) (1986) 1.35

Reference sera for antinuclear antibodies. I. Antibodies to native DNA, Sm, nuclear RNP, and SS-B/La. Arthritis Rheum (1982) 1.33

Circulating immune complexes in active Behçet's disease. Clin Exp Immunol (1978) 1.32

Studies of the antibodies in pemphigoid and pemphigus. J Lab Clin Med (1973) 1.31

Lymphocytotoxicity in recurrent aphthous stomatitis. Lymphocytotoxicity for oral epithelial cells in recurrent aphthous stomatitis and Bechet syndrome. Arch Dermatol (1974) 1.30

Peripheral neuropathy in primary Sjögren's syndrome. Neurology (1989) 1.28

Cytoplasmic and intranuclear electron-dense bodies in the myeloma cell. Arch Pathol (1966) 1.24

Untoward response with topical fluorouracil. Arch Dermatol (1968) 1.24

An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement. J Invest Dermatol (1982) 1.23

Pleural fluid complement, complement conversion, and immune complexes in immunologic and nonimmunologic diseases. J Lab Clin Med (1977) 1.23

Immunologic tests in the diagnosis of rheumatic diseases. Part I. Bull Rheum Dis (1977) 1.22

Necrotising vasculitis associated with lethal reticuloendothelial diseases. Br J Dermatol (1968) 1.21

Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis. Ann Intern Med (1972) 1.21

"Intermediate" cell types and mixed cell proliferation in multiple myeloma: electron microscopic observations. Blood (1966) 1.21

Circulating immune complexes in giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum (1980) 1.20

The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids. J Clin Invest (1973) 1.20

Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b. Immunology (1978) 1.18

The affinity of melanin for chloroquine. J Invest Dermatol (1965) 1.17

Correlation of pemphigoid and pemphigus antibody titres with activity of disease. Br J Dermatol (1971) 1.15

Negative complement immunofluorescence in pemphigus. J Invest Dermatol (1971) 1.15

Treatment of lupus nephritis with prednisone and combined prednisone and azathioprine. Ann Intern Med (1972) 1.14

Hypocomplementemic urticarial vasculitis: association with chronic obstructive pulmonary disease. Mayo Clin Proc (1982) 1.12

Immunoglobulin classes of antibodies produced in the primary and secondary responses in man. Clin Exp Immunol (1969) 1.12

Coexistence of ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum (1976) 1.11

Pulmonary and extrapulmonary sarcoidosis in relation to circulating immune complexes: a quantification of immune complexes by two radioimmunoassays. Am Rev Respir Dis (1977) 1.10

In vivo suppression of neutrophil chemotaxis by systemically and topically administered tetracycline. J Am Acad Dermatol (1983) 1.09

Amyloidosis masquerading as epidermolysis bullosa acquisita. Arch Dermatol (1969) 1.08

Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin. J Invest Dermatol (1980) 1.08

Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two years. Clin Exp Immunol (1978) 1.07

Immunoglobulin and complement deposition in skin of rheumatoid arthritis and systemic lupus erythematosus patients. Ann Rheum Dis (1976) 1.07

Meningeal myeloma. Arch Intern Med (1970) 1.07

Systemic lupus erythematosus. Studies of the antibodies bound to skin. J Clin Invest (1973) 1.06

Immunoglobulin complexes in sera of patients with malignancy. Int J Cancer (1977) 1.06

Mechanism of lesion production in pemphigus and pemphigoid. J Am Acad Dermatol (1982) 1.04

Comparison of three immunoassays for immune complexes in rheumatoid arthritis. Arthritis Rheum (1979) 1.04

Vasculitis associated with rheumatoid arthritis. Rheum Dis Clin North Am (1990) 1.03

Endomyocardiopathy with eosinophilia. Mayo Clin Proc (1976) 1.03

Impaired blastogenic response of lymphocytes from synovial fluid and peripheral blood of patients with rheumatoid arthritis. J Rheumatol (1976) 1.03

Basement-membrane antibodies in two patients with systemic lupus erythematosus. Lancet (1972) 1.03

Chloroquine: mechanism of action. Mayo Clin Proc (1967) 1.02

Human necrotizing vasculitis: immunoglobulins and complement in vessel walls of cutaneous lesions and normal skin. J Invest Dermatol (1975) 1.02

Comparative study of NZB mice under germfree and conventional conditions. J Rheumatol (1975) 1.02

Lymphoid neoplasia following connective tissue disease. Mayo Clin Proc (1979) 1.02

Absence of activity of first component of complement in man: association with thymic alymphoplasia and defective inflammatory response. J Lab Clin Med (1967) 1.00

Pemphigus antibodies: their role in disease. J Invest Dermatol (1971) 1.00

Cigarette smoking, disease severity and autoantibody expression in African Americans with recent-onset rheumatoid arthritis. Ann Rheum Dis (2008) 0.99

Behçet's disease associated with a lymphoproliferative disorder, mixed cryoglobulinemia, and an immune complex mediated vasculitis. J Rheumatol (1978) 0.98

Vasculitis associated with malignancy. Curr Opin Rheumatol (1992) 0.98

Characterization of lymph node histology in adult onset Still's disease. J Rheumatol (1989) 0.97

Vasculitis in hairy cell leukemia: review of literature and consideration of possible pathogenic mechanisms. J Rheumatol (1986) 0.96

The effect of immunosuppressive and anti-inflammatory drugs on monocyte function in vitro. J Lab Clin Med (1977) 0.96

Familial myeloma. Report of eight families and a study of serum proteins in their relatives. Am J Med (1974) 0.95

Periosteal new bone formation in polyarteritis nodosa: a syndrome involving the lower extremities. Arthritis Rheum (1975) 0.94

The effects of dimethyl sulfoxide on nerve conduction. Ann N Y Acad Sci (1967) 0.94

Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile. Clin Exp Immunol (1974) 0.94

Trial of platelet-inhibiting drug in scleroderma. Double-blind study with dipyridamole and aspirin. Arthritis Rheum (1984) 0.94

Interspecific variation in microsatellites isolated from tuco-tucos (Rodentia: Ctenomyidae). Mol Ecol (1999) 0.93

Hyperviscosity syndrome associated with immunoglobulin A myeloma. Am J Med Sci (1972) 0.93

Failure to transfer bullous pemphigoid with serum from patients. Proc Soc Exp Biol Med (1971) 0.93

Conservation genetics of the endangered Pampas deer (Ozotoceros bezoarticus). Mol Ecol (1998) 0.93

Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol (1977) 0.93

Cholinesterase inhibitory property of dimethyl sulphoxide. Nature (1966) 0.93

Morbidity impact of rheumatoid arthritis on society. Am J Med (1985) 0.92

Urinary adenosine and aminoimidazolecarboxamide excretion in methotrexate-treated patients with psoriasis. Arch Dermatol (1999) 0.92

Hemoglobin Malmö Beta-97 (FG-4) histidine--glutamine: a cause of polycythemia. J Clin Invest (1972) 0.92